CDC Reveals 4% of U.S. Adults Use Cannabis Daily for Sleep

By VirentaNews Staff — May 16, 2026

One in every 25 American adults—approximately 4% of the adult population—uses cannabis on a frequent basis specifically to improve sleep, according to the latest data from the Centers for Disease Control and Prevention (CDC). This trend, drawn from a nationally representative survey, underscores a quiet but profound shift in how individuals are managing sleep disturbances outside of traditional medicine. While prescription sleep aids like zolpidem and benzodiazepines remain in use, a growing segment of the population is turning to cannabinoids such as THC and CBD as a self-prescribed remedy. Public health experts caution that while short-term relief may be evident, the long-term consequences of nightly cannabis use for sleep remain poorly understood, particularly regarding cognitive function, dependency risk, and disruption of natural sleep architecture.

Why Sleep Aid Use Is Evolving

The CDC findings come amid a broader cultural and legislative shift toward cannabis acceptance across the United States. As of 2024, 38 states have legalized medical cannabis, and 24 permit recreational use, making the drug more accessible than ever. With rising rates of insomnia and stress-related sleep disorders—exacerbated by the pandemic and modern digital lifestyles—many adults are seeking alternatives to pharmaceuticals, which often carry side effects like grogginess, tolerance build-up, and addiction. Cannabis, particularly strains high in cannabidiol (CBD) or balanced in tetrahydrocannabinol (THC) and CBD, is increasingly marketed as a natural sleep aid. However, clinical guidelines remain cautious, citing insufficient evidence to support its long-term efficacy or safety for treating chronic insomnia.

Who Is Using Cannabis for Sleep?

The CDC data, collected through the National Health and Nutrition Examination Survey (NHANES), reveals that frequent cannabis use for sleep is more common among adults aged 30 to 59, particularly those with diagnosed anxiety, chronic pain, or sleep disorders. Women are slightly more likely than men to report using cannabis specifically for sleep, and users often combine it with other relaxation techniques like meditation or melatonin supplementation. Most users report consuming edibles or vape products rather than smoking, perceiving these methods as safer or more controlled. While the 4% figure may seem modest, it represents nearly 10 million adults who are integrating cannabis into their nightly routines—a behavior that public health officials say warrants closer monitoring, especially as usage normalizes.

What the Science Says About Cannabis and Sleep

Research on cannabis and sleep presents a complex picture. A 2017 review published in Nature and Science of Sleep found that THC can reduce sleep onset latency—the time it takes to fall asleep—while CBD may improve sleep quality and reduce nighttime awakenings, especially in individuals with anxiety. However, long-term use may lead to tolerance, requiring higher doses for the same effect, and may disrupt REM sleep, the stage critical for memory consolidation and emotional regulation. Withdrawal from chronic use can also trigger rebound insomnia and vivid dreams. Experts emphasize that most studies are short-term or observational, and robust randomized controlled trials are still lacking. The CDC warns that self-medication without clinical oversight risks masking underlying sleep conditions like sleep apnea or circadian rhythm disorders.

Public Health Implications of Nightly Use

The normalization of cannabis for sleep carries significant public health implications. While occasional use may pose minimal risk for healthy adults, daily reliance could lead to cannabis use disorder, affecting an estimated 10% of long-term users. Adolescents and young adults are particularly vulnerable to cognitive impacts, though the CDC data focuses on adults over 18. There are also concerns about inconsistent product labeling, potency variability, and contamination in unregulated markets. Moreover, older adults using cannabis alongside prescription medications face potential drug interactions, especially with sedatives, antidepressants, or blood thinners. As use grows, healthcare providers are urged to routinely screen for cannabis use during sleep evaluations and to educate patients on risks versus benefits.

Expert Perspectives

“We’re seeing a grassroots pharmacopeia emerge where patients trust anecdotal evidence over clinical trials,” says Dr. Rebecca Stone, a sleep neurologist at Johns Hopkins. “Cannabis can help some people fall asleep faster, but it’s not a cure for chronic insomnia.” In contrast, Dr. Marcus Lee, a researcher at the University of California, San Francisco, argues that “for patients who’ve failed conventional treatments, cannabis offers a viable alternative under medical supervision.” The American Academy of Sleep Medicine does not currently recommend cannabis as a treatment for insomnia, urging more research. The tension lies between patient autonomy and evidence-based medicine—a balance that regulators and clinicians must now navigate.

Going forward, scientists are calling for large-scale, longitudinal studies to assess how nightly cannabis use affects sleep quality, mental health, and overall well-being over time. As federal cannabis research barriers ease, trials funded by the National Institutes of Health are underway to evaluate standardized cannabinoid formulations for sleep disorders. Meanwhile, consumers should approach cannabis as they would any sleep aid: with caution, awareness, and ideally, in consultation with a healthcare provider. The CDC’s data doesn’t just reveal a trend—it signals a shift in how Americans manage their health in the absence of accessible, effective sleep treatments.

Source: Norml